These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11979811)

  • 1. [Prokinetics of gastrointestinal system; its newer aspects with regard to motillity stimulants].
    Hongo M; Satake M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():382-8. PubMed ID: 11979811
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.
    Yang YJ; Bang CS; Baik GH; Park TY; Shin SP; Suk KT; Kim DJ
    BMC Gastroenterol; 2017 Jun; 17(1):83. PubMed ID: 28651565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency scale symptoms for gastroesophageal reflux disease (Frequency Scale for Symptoms of GERD) predicts need for addition of prokinetics to proton pump inhibitor therapy.
    Nandurkar S
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1165-7. PubMed ID: 18699977
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prokinetics in childhood].
    Gottrand F
    Arch Pediatr; 2010 Jun; 17(6):737-8. PubMed ID: 20654867
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 8. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
    Megens AA; Awouters FH; Niemegeers CJ
    Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of clebopride, domperidone, metopimazine, and trimebutine as antiemetics and inducers of gastrointestinal peristalsis].
    Berga P; Beckett PR; Massó JL; Roberts DJ
    Arch Farmacol Toxicol; 1981 Apr; 7(1):189-92. PubMed ID: 7198896
    [No Abstract]   [Full Text] [Related]  

  • 10. Mosapride and postoperative ileus.
    Korolkiewicz R; Sein-Anand J
    Dis Colon Rectum; 2009 Apr; 52(4):751-2; author reply 752. PubMed ID: 19404086
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study on the effects of domperidone, metoclopramide, clebopride and trimebutine on the gastro-duodenal preparation of the guinea pig.
    Schuurkes JA; Helsen LF; Van Nueten JM
    Jpn J Pharmacol; 1985 Oct; 39(2):123-30. PubMed ID: 4087563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of four medications associated with gastrointestinal motility on Oddi sphincter in the rabbit.
    Li C; Qian W; Hou X
    Pancreatology; 2009; 9(5):615-20. PubMed ID: 19657216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of prokinetic agents on the electrical activity of stomach and duodenum in rats].
    Li F; Zou Y; Huang T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 34(7):599-602. PubMed ID: 19648670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effects of gastrointestinal-motility stimulating agents on non-ulcer dyspepsia].
    Harasawa S; Takayasu H
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):82-5. PubMed ID: 2273692
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of dopamine D2 receptor antagonists on gastrointestinal motility].
    Mizumoto A; Ito A
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):65-9. PubMed ID: 2273688
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of severely delayed gastric emptying].
    Samsom M; Gooszen HG
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1945-8. PubMed ID: 11048557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of non-ulcer dyspepsia].
    Cortese I; Maselli MA
    Clin Ter; 1990 Apr; 133(2):103-7. PubMed ID: 2140745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia.
    Cho KH; Choi YK; Kang JH; Choi HG; Yong CS; Park YJ
    Int J Pharm; 2010 Nov; 400(1-2):145-52. PubMed ID: 20826201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.